Effective treatments for ALS have eluded scientists for decades. A new examination of the immune system shows the appeal of personalized medicine for future care.
An open label extension shows additional benefit from a drug currently being tested for patients with Lou Gehrig’s disease.
Positive clinical trial points to possible additional option for patients with Lou Gehrig’s disease. A study investigator explains the excitement and the caution.
Experts describe a method that could be used to spot the complex brain disease.
Recent studies are uncovering how diabetes may structurally alter the brain, leading to cognitive decline.
Michigan Medicine researchers identify a potential therapeutic target for neurodegenerative conditions using animal models.